Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Advertisement

British Journal of Cancer
  • View all journals
  • Search
  • My Account Login
  • Content Explore content
  • About the journal
  • Publish with us
  • Sign up for alerts
  • RSS feed
  1. nature
  2. british journal of cancer
  3. regular article
  4. article
Cytotoxic response of ovarian cancer cell lines to IFN-γ is associated with sustained induction of IRF-1 and p21 mRNA
Download PDF
Download PDF
  • Regular Article
  • Open access
  • Published: 28 May 1999

Cytotoxic response of ovarian cancer cell lines to IFN-γ is associated with sustained induction of IRF-1 and p21 mRNA

  • F Burke1,
  • P D Smith2,
  • M R Crompton2,
  • C Upton3 &
  • …
  • F R Balkwill1 

British Journal of Cancer volume 80, pages 1236–1244 (1999)Cite this article

  • 1134 Accesses

  • 45 Citations

  • Metrics details

This article has been updated

Summary

Intereferon-γ (IFN-γ) has some anti-tumour activity in human ovarian cancer. This cytokine inhibited proliferation in three of four ovarian cancer cell lines in vitro. We then compared the action of IFN-γ in two cell lines, one sensitive and one resistant to its growth inhibitory effects. IFN-γ signalling appeared normal in both cell lines, with stat1 DNA binding activity detectable at 30 min. Continuous exposure to IFN-γ for 2–3 days was necessary for an irreversible effect on cell growth and apoptosis in cells sensitive to growth inhibition. During this time there was an increase in mRNA for the CKI p21, but no alterations in mRNA levels for other members of the CKI family. Maintenance of p21 mRNA required continuous mRNA synthesis. mRNA for the transcription factor IRF-1 was also induced in growth inhibited cells with similar kinetics to those observed for p21. Maximal induction of both p21 and IRF-1 mRNA was observed after 2–3 days IFN-γ exposure as the cells became committed to cell death. There was also a rapid increase in p21 and IRF-1 mRNA in cells resistant to the growth inhibitory effects of IFN-γ, but this increase was not maintained. Thus, continuous interaction with the IFN-γ receptor, together with a sustained induction of p21 and IRF-1, is associated with growth inhibitory and apoptotic effects of IFN-γ in ovarian cancer cells.

Similar content being viewed by others

Interferon-ε is a tumour suppressor and restricts ovarian cancer

Article 16 August 2023

Ginsenoside Rh2 in combination with IFNγ potentiated the anti-cancer effect by enhancing interferon signaling response in colorectal cancer cells

Article 22 April 2025

Interferon-γ: teammate or opponent in the tumour microenvironment?

Article 21 June 2021

Article PDF

Change history

  • 16 November 2011

    This paper was modified 12 months after initial publication to switch to Creative Commons licence terms, as noted at publication

References

  • Andrews, N. C. & Faller, D. V. (1991). A rapid micropreparation technique for extraction of DNA-binding proteins from limiting numbers of mammalian cells. Nucleic Acids Res 19: 2499

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Bromberg, J. F., Horvath, C. M., Wen, Z. L., Schreiber, R. D. & Darnell, J. E. (1996). Transcriptionally active stat1 is required for the antiproliferative effects of both interferon-alpha and interferon-gamma. Proc Natl Acad Sci USA 93: 7673–7678.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Buard, A., Vivo, C., Monnet, I., Boutin, C., Pilatte, Y. & Jaurand, M. (1998). Human malignant mesothelioma cell growth: activation of Janus kinase 2 and signal transducer and activator of transcription 1α for inhibition by interferon-γ. Cancer Res 58: 840–847.

    CAS  PubMed  Google Scholar 

  • Burke, F., East, N., Upton, C., Patel, K. & Balkwill, F. R. (1997). Interferon gamma induces cell cycle arrest and apoptosis in a model of ovarian cancer: enhancement of effect by batimastat. Eur J Cancer 33: 1114–1121.

    Article  CAS  PubMed  Google Scholar 

  • Chin, Y. E., Kitagawa, M., Su, W. C. S., You, Z. H., Iwamoto, Y. & Fu, X. Y. (1996). Cell-growth arrest and induction of cyclin-dependent kinase inhibitor p21 (waf1/cip1) mediated by stat1. Science 272: 719–722.

    Article  CAS  PubMed  Google Scholar 

  • Church, G. M. & Gilbert, W. (1984). Genomic sequencing. Proc Natl Acad Sci USA 81: 1991–1995.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Elbendary, A., Berchuck, A., Davis, P., Havrilesky, L., Bast, R. C. Jr, Iglehart, J. D. & Marks, J. R. (1994). Transforming growth factor beta 1 can induce CIP1/WAF1 expression independent of the p53 pathway in ovarian cancer cells. Cell Growth Differ 5: 1301–1307.

    CAS  PubMed  Google Scholar 

  • Fan, Z., Lu, Y., Wu, X. P., Deblasio, A., Koff, A. & Mendelsohn, J. (1995). Prolonged induction of p21 (cip1/waf1)/cdk2/PCNA complex by epidermal growth-factor receptor activation mediates ligand-induced A431 cell-growth inhibition. J Cell Biol 131: 235–242.

    Article  CAS  PubMed  Google Scholar 

  • Gavrieli, Y., Sherman, Y. & Ben Sasson, S. A. (1992). Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol 119: 493–501.

    Article  CAS  PubMed  Google Scholar 

  • Harvat, B. L., Seth, P. & Jetten, A. M. (1997). The role of p27 (kip1) in γ-interferon-mediated growth arrest of mammary epithelial cells and related defects in mammary-carcinoma cells. Oncogene 14: 2111–2122.

    Article  CAS  PubMed  Google Scholar 

  • Hobeika, A. C., Subramaniam, P. S. & Johnson, H. M. (1997). IFN-α induces the expression of the cyclin-dependent kinase inhibitor p21 in human prostate-cancer cells. Oncogene 14: 1165–1170.

    Article  CAS  PubMed  Google Scholar 

  • Jakus, J. & Yeudall, W. A. (1996). Growth-inhibitory concentrations of EGF induce p21 (waf1/cip1) and alter cell-cycle control in squamous carcinoma-cells. Oncogene 12: 2369–2376.

    CAS  PubMed  Google Scholar 

  • Jeoung, D. I., Tang, B. & Sonenberg, M. (1995). Effects of tumor necrosis factor-alpha on antimitogenicity and cell cycle-related proteins in MCF-7 cells. J Biol Chem 270: 18367–18373.

    Article  CAS  PubMed  Google Scholar 

  • Langdon, S. P., Lawrie, S. S., FG, H., Hawkes, M. M., McDonald, M. M., Hayward, A., Ip, S., Hilgers, J., Leonard, R. C. F. & Smyth, J. F. (1988). Characterisation and properties of nine human ovarian adenocarcinoma cell lines. Cancer Res 48: 6166–6172.

    CAS  PubMed  Google Scholar 

  • Leaman, D. W., Leung, S., Li, X. & Stark, G. R. (1996). Regulation of STAT-dependent pathways by growth factors and cytokines. Faseb J 10: 1578–1588.

    Article  CAS  PubMed  Google Scholar 

  • Nicholson, S. E. & Hilton, D. J. (1998). The SOCS proteins: a new family of negative regulators of signal transduction. J Leukoc Biol 63: 665–668.

    Article  CAS  PubMed  Google Scholar 

  • Pujade-Lauraine, E., Guastalla, J-P, Colombo, N., Devillier, P., Franciois, E., Fumoleau, P., Monnier, A., Nooy, M., Mignot, L., Bugat, R., Marques, C., Mousseau, M., Netter, G., Maloisel, F., Larbaoui, S. & Brandely, M. (1996). Intraperitoneal recombinant interferon gamma in ovarian cancer patients with residual disease at second-look laparotomy. J Clin Oncol 14: 343–350.

    Article  CAS  PubMed  Google Scholar 

  • Sakamoto, H., Yasukawa, H., Masuhara, M., Tanimura, S., Sasaki, A., Yuge, K., Ohtsubo, M., Ohtsuka, A., Fujita, T., Ohta, T., Furukara, Y., Iwase, S., Yamada, H. & Yoshimura, A. (1998). A Janus kinase inhibitor, JAB, is an interferon-gamma-inducible gene and confers resistance to interferons. Blood 92: 1668–1676.

    CAS  PubMed  Google Scholar 

  • Sangfelt, O., Erickson, S., Einhorn, S. & Grander, D. (1997). Induction of cip/kip and INK 4 cyclin-dependent kinase inhibitors by interferon-α in hematopoietic-cell lines. Oncogene 14: 415–423.

    Article  CAS  PubMed  Google Scholar 

  • Tanaka, N., Ishihara, M., Lamphier, M. S., Nozawa, H., Matsuyama, T., Mak, T. W., Aizawa, S., Tokino, T., Oren, M. & Taniguchi, T. (1996). Cooperation of the tumour suppressors IRF-1 and p53 in response to DNA damage. Nature 382: 816–818.

    Article  CAS  PubMed  Google Scholar 

  • Taniguchi, T., Lamphier, M. S. & Tanaka, N. (1997). IRF-1: the transcription factor linking the interferon response and oncogenesis. Biochim Biophys Acta 1333: M9–17.

    CAS  PubMed  Google Scholar 

  • Towbin, H., Staehelin, T. & Gordon, J. (1979). Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci USA 76: 4350–4354.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Biological Therapies Laboratory, Imperial Cancer Research Fund, 44 Lincoln’s Inn Fields, London, WC2A 3PX, UK

    F Burke & F R Balkwill

  2. Electron Microscopy Laboratory, Imperial Cancer Research Fund, 44 Lincoln’s Inn Fields, London, WC2A 3PX, UK

    P D Smith & M R Crompton

  3. Institute of Cancer Research, Haddow Laboratories, 15 Cotswold Road, Sutton, SM2 5NG, Surrey, UK

    C Upton

Authors
  1. F Burke
    View author publications

    Search author on:PubMed Google Scholar

  2. P D Smith
    View author publications

    Search author on:PubMed Google Scholar

  3. M R Crompton
    View author publications

    Search author on:PubMed Google Scholar

  4. C Upton
    View author publications

    Search author on:PubMed Google Scholar

  5. F R Balkwill
    View author publications

    Search author on:PubMed Google Scholar

Rights and permissions

From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/

Reprints and permissions

About this article

Cite this article

Burke, F., Smith, P., Crompton, M. et al. Cytotoxic response of ovarian cancer cell lines to IFN-γ is associated with sustained induction of IRF-1 and p21 mRNA. Br J Cancer 80, 1236–1244 (1999). https://doi.org/10.1038/sj.bjc.6690491

Download citation

  • Received: 05 October 1998

  • Revised: 04 January 1999

  • Accepted: 06 January 1999

  • Published: 28 May 1999

  • Issue date: 01 June 1999

  • DOI: https://doi.org/10.1038/sj.bjc.6690491

Share this article

Anyone you share the following link with will be able to read this content:

Sorry, a shareable link is not currently available for this article.

Provided by the Springer Nature SharedIt content-sharing initiative

Keywords

  • interferon-γ
  • ovarian cancer
  • p21
  • stat1
  • IRF-1

This article is cited by

  • Low doses of IFN-γ maintain self-renewal of leukemia stem cells in acute myeloid leukemia

    • Xiaoling Xie
    • Wuju Zhang
    • Xiaochun Bai

    Oncogene (2023)

  • Novel Human Anti-PD-L1 mAbs Inhibit Immune-Independent Tumor Cell Growth and PD-L1 Associated Intracellular Signalling

    • Margherita Passariello
    • Anna Morena D’Alise
    • Claudia De Lorenzo

    Scientific Reports (2019)

  • Activated CD4+T cells enhance radiation effect through the cooperation of interferon-γ and TNF-α

    • Yixiang Wang
    • Soroosh Radfar
    • Hung T Khong

    BMC Cancer (2010)

  • A novel approach in the treatment of neuroendocrine gastrointestinal tumors: Additive antiproliferative effects of interferon-γ and meta-iodobenzylguanidine

    • Michael Höpfner
    • Andreas P Sutter
    • Hans Scherübl

    BMC Cancer (2004)

  • Malignant germ cell tumours of the testis express interferon-γ, but are resistant to endogenous interferon-γ

    • S Schweyer
    • A Soruri
    • A Fayyazi

    British Journal of Cancer (2003)

Download PDF

Advertisement

Explore content

  • Research articles
  • Reviews & Analysis
  • News & Comment
  • Current issue
  • Collections
  • Follow us on Twitter
  • Sign up for alerts
  • RSS feed

About the journal

  • Journal Information
  • Open access publishing
  • About the Editors
  • Contact
  • Special Issues
  • For Advertisers
  • Subscribe

Publish with us

  • For Authors & Referees
  • Language editing services
  • Submit manuscript

Search

Advanced search

Quick links

  • Explore articles by subject
  • Find a job
  • Guide to authors
  • Editorial policies

British Journal of Cancer (Br J Cancer)

ISSN 1532-1827 (online)

ISSN 0007-0920 (print)

nature.com sitemap

About Nature Portfolio

  • About us
  • Press releases
  • Press office
  • Contact us

Discover content

  • Journals A-Z
  • Articles by subject
  • protocols.io
  • Nature Index

Publishing policies

  • Nature portfolio policies
  • Open access

Author & Researcher services

  • Reprints & permissions
  • Research data
  • Language editing
  • Scientific editing
  • Nature Masterclasses
  • Research Solutions

Libraries & institutions

  • Librarian service & tools
  • Librarian portal
  • Open research
  • Recommend to library

Advertising & partnerships

  • Advertising
  • Partnerships & Services
  • Media kits
  • Branded content

Professional development

  • Nature Awards
  • Nature Careers
  • Nature Conferences

Regional websites

  • Nature Africa
  • Nature China
  • Nature India
  • Nature Japan
  • Nature Middle East
  • Privacy Policy
  • Use of cookies
  • Legal notice
  • Accessibility statement
  • Terms & Conditions
  • Your US state privacy rights
Springer Nature

© 2025 Springer Nature Limited